Purkersdorf, Austria

Dirk Strickmann

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 3 EPO patents. Top assignee: Ariva Med Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dirk Strickmann. Retrieved from https://idiyas.com/inventor/dirk-strickmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dirk Strickmann: Innovator in Therapeutics

Introduction

Dirk Strickmann is a notable inventor based in Purkersdorf, Austria. He is currently associated with Nabriva Therapeutics GmbH, a company focused on developing innovative therapies. Although he holds no patents, his contributions to the field of therapeutics are significant.

Latest Patents

Dirk Strickmann has not registered any patents to date. However, his work in the pharmaceutical industry continues to influence the development of new treatments.

Career Highlights

Throughout his career, Dirk has been involved in various projects that aim to improve patient outcomes. His expertise in therapeutics has made him a valuable asset to Nabriva Therapeutics GmbH.

Collaborations

Dirk collaborates with esteemed colleagues such as Klaus Thirring and Werner Heilmayer. Their combined efforts contribute to the advancement of therapeutic innovations.

Conclusion

Dirk Strickmann is a dedicated inventor whose work at Nabriva Therapeutics GmbH reflects his commitment to improving healthcare. His collaborations and career highlights showcase his influence in the field of therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…